Metabolites and Transformation Products of Pharmaceuticals in the Aquatic Environment as Contaminants of Emerging Concern

Transformation Products of Emerging Contaminants in the Environment: Analysis, Processes, Occurrence, Effects and Risks

Volumn , Issue , 2014, Pages 413-458

  Michael, Irene ^a   Vasquez, Marlen Ines ^a   Hapeshi, Evroula ^a   Haddad, Tarek ^b   Baginska, Ewelina ^b   Kümmerer, Klaus ^b   Fatta Kassinos, Despo ^a  

^a UNIVERSITY OF CYPRUS   (Cyprus)

^b LEUPHANA UNIVERSITY OF LÜNEBURG   (Germany)

Author keywords

Advanced oxidation processes; Biotic and abiotic degradation; Metabolites; Pharmaceuticals; Transformation products

Indexed keywords

BIOMOLECULES; DRUG PRODUCTS; EFFLUENTS; METABOLITES; PHOTOLYSIS; PHYSIOLOGY; SEWAGE TREATMENT PLANTS;

ADVANCED OXIDATION PROCESSES; BIOTIC AND ABIOTIC DEGRADATIONS; CONTAMINANTS OF EMERGING CONCERNS; NEW CHEMICAL ENTITIES; PHARMACEUTICAL COMPOUNDS; STRUCTURAL TRANSFORMATION; TECHNOLOGICAL PROCESS; TRANSFORMATION PRODUCTS;

EFFLUENT TREATMENT;

EID: 84982263406     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118339558.ch14     Document Type: Chapter

References (187)

1. Jones, O.A.H., Voulvoulis, N., and Lester, J.N. (2001) Human pharmaceuticals in the aquatic environment a review. Environmental Technology, 22, 1383-1394.
2. Perez, S., Eichhorn, P., and Barcelo, D. (2007) Structural characterization of photodegradation products of enalapril and its metabolite enalaprilat obtained under simulated environmental conditions by hybrid quadrupole-linear ion trap-MS and quadrupole-time-of-flight-MS. Analytical Chemistry, 79, 8293-8300.
3. Cha, J.M., Yang, S., and Carlson, K.H. (2006) Trace determination of b-lactam antibiotics in surface water and urban wastewater using liquid chromatography combined with electrospray tandem mass spectrometry. Journal of Chromatography. A, 1115, 46-57.
4. Li, B., Zhang, T., Xu, Z., and Fang, H.H.P. (2009) Rapid analysis of 21 antibiotics of multiple classes in municipal wastewater using ultra performance liquid chromatography-tandem mass spectrometry. Analytica Chimica Acta, 645, 64-72.
5. Kern, S., Baumgartner, R., Helbling, D.E. et al. (2010) A tiered procedure for assessing the formation of biotransformation products of pharmaceuticals and biocides during activated sludge treatment. Journal of Environmental Monitoring, 12, 2100-2111.
6. Fatta-Kassinos, D., Vasquez, M.I., and Kümmerer, K. (2011) Transformation products of pharmaceuticals in surface waters and wastewater formed during photolysis and advanced oxidation processes - Degradation, elucidation of byproducts and assessment of their biological potency. Chemosphere, 85, 693-709.
7. Kümmerer, K., Alexy, R., Hüttig, J., and Schöll, A. (2004) Standardized tests fail to assess the effects of antibiotics on environmental bacteria. Water Research, 38, 2111-2116.
8. Andreozzi, R., Raffaele, M., and Nicklas, P. (2003) Pharmaceuticals in STP effluents and their solar photodegradation in aquatic environment. Chemosphere, 50, 1319-1330.
9. Klavarioti, M., Mantzavinos, D., and Kassinos, D. (2009) Removal of residual pharmaceuticals from aqueous systems by advanced oxidation processes. Environment International, 35, 402-417.
10. Legrini, O., Oliveros, E., and Braun, A.M. (1993) Photochemical processes for water treatment. Chemical Reviews, 93, 671-698.
11. Malato, S., Fernández-Ibáñez, P., Maldonado, M.I. et al. (2009) Decontamination and disinfection of water by solar photocatalysis: Recent overview and trends. Catalysis Today, 147, 1-59.
12. Boxall, A.B.A., Sinclair, C.J., Fenner, K. et al. (2004) Peer Reviewed: When synthetic chemicals degrade in the environment. Environmental Science & Technology, 38, 368-375.
13. Fenner, K. (2009) Transformation products- relevant risk factors? Eawag News, 67e, 15-18.
14. Timbrell, J.A. (2008) Factors affecting toxic responses: metabolism, in Principles of Biochemical Toxicology (ed. J.A. Timbrell), Informa Healthcare, New York, USA.
15. Lindberg, R.H., Björklund, K., Rendahl, P. et al. (2007) Environmental risk assessment of antibiotics in the Swedish environment with emphasis on sewage treatment plants. Water Research, 41, 613-619.
16. Trenholm, R.A., Vanderford, B.J., and Snyder, S.A. (2009) On-line solid phase extraction LC- MS/MS analysis of pharmaceutical indicators in water: A green alternative to conventional methods. Talanta, 79, 1425-1432.
17. Bruce, G.M., Pleus, R.C., and Snyder, S.A. (2010) Toxicological relevance of pharmaceuticals in drinking water. Environmental Science & Technology, 44, 5619-5626.
18. Kumar, A. and Xagoraraki, I. (2010) Pharmaceuticals, personal care products and endocrinedisrupting chemicals in U.S. surface and finished drinking waters: A proposed ranking system. The Science of the Total Environment, 408, 5972-5989.
19. Snyder, S.A. (2008) Occurrence, treatment, and toxicological relevance of EDCs and pharmaceuticals in water. Ozone-Science & Engineering, 30, 65-69.
20. López-Serna, R., Petrovíc, M., and Barceló, D. (2012) Occurrence and distribution of multi-class pharmaceuticals and their active metabolites and transformation products in the Ebro River basin (NE Spain). The Science of the Total Environment, 440, 280-289.
21. Zwiener, C. (2007) Occurrence and analysis of pharmaceuticals and their transformation products in drinking water treatment. Analytical and Bioanalytical Chemistry, 387, 1159-1162.
22. Celiz, M.D., Tso, J., and Aga, D.S. (2009) Pharmaceutical metabolites in the environment: Analytical challenges and ecological risks. Environmental Toxicology and Chemistry, 28, 2473-2484.
23. Daughton, C.G. and Ternes, T.A. (1999) Pharmaceuticals and personal care products in the environment: Agents of subtle change? Environmental Health Perspectives, 107, 907-938.
24. Bound, J.P. and Voulvoulis, N. (2004) Pharmaceuticals in the aquatic environment--a comparison of risk assessment strategies. Chemosphere, 56, 1143-1155.
25. Cleuvers, M. (2003) Aquatic ecotoxicity of pharmaceuticals including the assessment of combination effects. Toxicology Letters, 142, 185-194.
26. Cunningham, V.L., Buzby, M., Hutchinson, T. et al. (2006) Effects of human pharmaceuticals on aquatic life: Next steps. Environmental Science & Technology, 40, 3456-3462.
27. Ternes, T.A. (1998) Occurrence of drugs in German sewage treatment plants and rivers. Water Research, 32, 3245-3260.
28. Comeau, F., Surette, C., Brun, G.L., and Losier, R. (2008) The occurrence of acidic drugs and caffeine in sewage effluents and receiving waters from three coastal watersheds in Atlantic Canada. The Science of the Total Environment, 396, 132-146.
29. Carrara, C., Ptacek, C.J., Robertson, W.D. et al. (2008) Fate of pharmaceutical and trace organic compounds in three septic system plumes, Ontario, Canada. Environmental Science & Technology, 42, 2805-2811.
30. Verenitch, S.S., Lowe, C.J., and Mazumder, A. (2006) Determination of acidic drugs and caffeine in municipal wastewaters and receiving waters by gas chromatography-ion trap tandem mass spectrometry. Journal of Chromatography A, 1116, 193-203.
31. Lee, H., Peart, T.E., and Svoboda, M.L. (2005) Determination of endocrine-disrupting phenols, acidic pharmaceuticals, and personal-care products in sewage by solid-phase extraction and gas chromatography-mass spectrometry. Journal of Chromatography A, 1094, 122-129.
32. Lajeunesse, A., Gagnon, C., and Sauve, S. (2008) Determination of basic antidepressants and their N-Desmethyl metabolites in raw sewage and wastewater using solid-phase extraction and liquid chromatography-tandem mass spectrometry. Analytical Chemistry, 80, 5325-5333.
33. Benotti, M.J., Trenholm, R.A., Vanderford, B.J. et al. (2009) Pharmaceuticals and endocrine disrupting compounds in U.S. drinking water. Environmental Science & Technology, 43, 597-603.
34. Langford, K. and Thomas, K.V. (2011) Input of selected human pharmaceutical metabolites into the Norwegian aquatic environment. Journal of Environmental Monitoring, 13, 416-421.
35. Miao, X. and Metcalfe, C.D. (2003) Determination of carbamazepine and its metabolites in aqueous samples using liquid chromatography-electrospray tandem mass spectrometry. Analytical Chemistry, 75, 3731-3738.
36. Miao, X., Yang, J., and Metcalfe, C.D. (2005) Carbamazepine and its metabolites in wastewater and in biosolids in a municipal wastewater treatment plant. Environmental Science & Technology, 39, 7469-7475.
37. De Jongh, C.M., Kooij, P.J.F., de Voogt, P., and ter Laak, T.L. (2012) Screening and human health risk assessment of pharmaceuticals and their transformation products in Dutch surface waters and drinking water. The Science of the Total Environment, 427-428, 70-77.
38. Zhao, X. and Metcalfe, C.D. (2008) Characterizing and compensating for matrix effects using atmospheric pressure chemical ionization liquid chromatography-tandem mass spectrometry: Analysis of neutral pharmaceuticals in municipal wastewater. Analytical Chemistry, 80, 2010-2017.
39. Koutsouba, V., Heberer, T., Fuhrmann, B. et al. (2003) Determination of polar pharmaceuticals in sewage water of Greece by gas chromatography-mass spectrometry. Chemosphere, 51, 69-75.
40. Reddersen, K. and Heberer, T. (2003) Multi-compound methods for the detection of pharmaceutical residues in various waters applying solid phase extraction (SPE) and gas chromatography with mass spectrometric (GC-MS) detection. Journal of Separation Science, 26, 1443-1450.
41. Castiglioni, S., Bagnati, R., Calamari, D. et al. (2005) A multiresidue analytical method using solid-phase extraction and high-pressure liquid chromatography tandem mass spectrometry to measure pharmaceuticals of different therapeutic classes in urban wastewaters. Journal of Chromatography A, 1092, 206-215.
42. Hilton, M. and Thomas, K. (2003) Determination of selected human pharmaceutical compounds in effluent and surface water samples by high-performance liquid chromatography-electrospray tandem mass spectrometry. Journal of Chromatography A, 1015, 129-141.
43. Bueno, M.J.M., Agüera, A., Hernando, M.D. et al. (2009) Evaluation of various liquid chromatography- quadrupole-linear ion trap-mass spectrometry operation modes applied to the analysis of organic pollutants in wastewaters. Journal of ChromatographyA, 1216, 5995-6002.
44. Lin, A.Y., Yu, T., and Lateef, S.K. (2009) Removal of pharmaceuticals in secondary wastewater treatment processes in Taiwan. Journal of Hazardous Materials, 167, 1163-1169.
45. Weigel, S., Berger, U., Jensen, E. et al. (2004) Determination of selected pharmaceuticals and caffeine in sewage and seawater from Tromsø/Norway with emphasis on ibuprofen and its metabolites. Chemosphere, 56, 583-592.
46. Hernando, M., Heath, E., Petrovic, M., and Barcelo, D. (2006) Trace-level determination of pharmaceutical residues by LC-MS/MS in natural and treated waters. A pilot-survey study. Analytical and Bioanalytical Chemistry, 385, 985-991.
47. Roberts, P.H. and Thomas, K.V. (2006) The occurrence of selected pharmaceuticals in wastewater effluent and surface waters of the lower Tyne catchment. The Science of the Total Environment, 356, 143-153.
48. Fent, K., Weston, A.A., and Caminada, D. (2006) Ecotoxicology of human pharmaceuticals. Aquatic Toxicology, 76, 122-159.
49. Metcalfe, C., Tindale, K., Li, H. et al. (2010) Illicit drugs in Canadian municipal wastewater and estimates of community drug use. Environmental Pollution, 158, 3179-3185.
50. Xu, W., Zhang, G., Li, X. et al. (2007) Occurrence and elimination of antibiotics at four sewage treatment plants in the Pearl River Delta (PRD), South China. Water Research, 41, 4526-4534.
51. Gulkowska, A., He, Y., So, M.K. et al. (2007) The occurrence of selected antibiotics in Hong Kong coastal waters. Marine Pollution Bulletin, 54, 1287-1293.
52. Lin, A.Y. and Tsai, Y. (2009) Occurrence of pharmaceuticals in Taiwan's surface waters: Impact of waste streams from hospitals and pharmaceutical production facilities. The Science of the Total Environment, 407, 3793-3802.
53. Vasskog, T., Bergersen, O., Anderssen, T. et al. (2009) Depletion of selective serotonin reuptake inhibitors during sewage sludge composting. Waste Management, 29, 2808-2815.
54. Bendz, D., Paxéus, N.A., Ginn, T.R., and Loge, F.J. (2005) Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Höje River in Sweden. Journal of Hazardous Materials, 122, 195-204.
55. Stumpf, M., Ternes, T.A., Haberer, K., and Baumann, W. (1998) Isolierung von ibuprofenmetaboliten und deren bedeutung als kontaminanten der aquatischen umwelt. Vom Wasser, 91, 291-303.
56. Boleda, M.R., Galceran, M.T., and Ventura, F. (2009) Monitoring of opiates, cannabinoids and their metabolites in wastewater, surface water and finished water in Catalonia, Spain. Water Research, 43, 1126-1136.
57. Letzel, M., Weiss, K., Schüssler, W., and Sengl, M. (2010) Occurrence and fate of the human pharmaceutical metabolite ritalinic acid in the aquatic system. Chemosphere, 81, 1416-1422.
58. Reddersen, K., Heberer, T., and Dünnbier, U. (2002) Identification and significance of phenazone drugs and their metabolites in ground- and drinking water. Chemosphere, 49, 539-544.
59. Göbel, A., Thomsen, A., McArdell, C.S. et al. (2005) Occurrence and sorption behavior of sulfonamides, macrolides, and trimethoprim in activated sludge treatment. Environmental Science & Technology, 39, 3981-3989.
60. Le-Minh, N., Stuetz, R.M., and Khan, S.J. (2012) Determination of six sulfonamide antibiotics, two metabolites and trimethoprim in wastewater by isotope dilution liquid chromatography/tandem mass spectrometry. Talanta, 89, 407-416.
61. Zaugg, S., Zhang, X., Sweedler, J., and Thormann, W. (2001) Determination of salicylate, gentisic acid and salicyluric acid in human urine by capillary electrophoresis with laser-induced fluorescence detection. Journal of Chromatography B, 752, 17-31.
62. Henschel, K.P., Wenzel, A., Diedrich, M., and Fliedner, A. (1997) Environmental hazard assessment of pharmaceuticals. Regulatory Toxicology and Pharmacology, 25, 220-225.
63. Marques, C.R., Abrantes, N., and GonScalves, F. (2004) Life-history traits of standard and autochthonous cladocerans: I. Acute and chronic effects of acetylsalicylic acid. Environmental Toxicology, 19, 518-526.
64. Ju, C. and Uetrecht, J.P. (1999) Detection of 2-Hydroxyiminostilbene in the urine of patients taking carbamazepine and its oxidation to a reactive iminoquinone intermediate. The Journal of Pharmacology and Experimental Therapeutics, 288, 51-56.
65. Nalečz-Jawecki, G. (2007) Evaluation of the in vitro biotransformation of fluoxetine with HPLC, mass spectrometry and ecotoxicological tests. Chemosphere, 70, 29-35.
66. Joss, A., Keller, E., Alder, A.C. et al. (2005) Removal of pharmaceuticals and fragrances in biological wastewater treatment. Water Research, 39, 3139-3152.
67. Göbel, A., McArdell, C.S., Joss, A. et al. (2007) Fate of sulfonamides, macrolides, and trimethoprim in different wastewater treatment technologies. The Science of the Total Environment, 372, 361-371.
68. Zhou, S., Chan, E., Duan, W. et al. (2005) Drug bioactivation covalent binding to target proteins and toxicity relevance. Drug Metabolism Reviews, 37, 41-213.
69. Pérez, S. and Barceló, D. (2007) Application of advanced MS techniques to analysis and identification of human and microbial metabolites of pharmaceuticals in the aquatic environment. TrAC Trends in Analytical Chemistry, 26, 494-514.
70. Huschek, G., Hansen, P.D., Maurer, H.H. et al. (2004) Environmental risk assessment of medicinal products for human use according to european commission recommendations. Environmental Toxicology, 19, 226-240.
71. Farré, M.l., Pérez, S., Kantiani, L., and Barceló, D. (2008) Fate and toxicity of emerging pollutants, their metabolites and transformation products in the aquatic environment. TrAC Trends in Analytical Chemistry, 27, 991-1007.
72. Kagle, J., Porter, A.W., Murdoch, R.W. et al. (2009) Biodegradation of pharmaceutical and personal care products. Advances in Applied Microbiology, 67, 65-108.
73. Ternes, T.A., Kreckel, P., and Mueller, J. (1999) Behaviour and occurrence of estrogens in municipal sewage treatment plants-II. Aerobic batch experiments with activated sludge. The Science of the Total Environment, 225, 91-99.
74. Carballa, M., Omil, F., Lema, J.M. et al. (2004) Behavior of pharmaceuticals, cosmetics and hormones in a sewage treatment plant. Water Research, 38, 2918-2926.
75. Prasse, C., Wagner, M., Schulz, R., and Ternes, T. (2011) Biotransformation of the antiviral drugs acyclovir and penciclovir in activated sludge treatment. Environmental Science & Technology, 45, 2761-2769.
76. Radjenovíc, J., Pérez, S., Petrovíc, M., and Barceló, D. (2008) Identification and structural characterization of biodegradation products of atenolol and glibenclamide by liquid chromatography coupled to hybrid quadrupole time-of-flight and quadrupole ion trap mass spectrometry. Journal of Chromatography A, 1210, 142-153.
77. Terzic, S., Senta, I., Matosic, M., and Ahel, M. (2011) Identification of biotransformation products of macrolide and fluoroquinolone antimicrobials in membrane bioreactor treatment by ultrahigh- performance liquid chromatography/quadrupole time-of-flight mass spectrometry. Analytical and Bioanalytical Chemistry, 401(1), 353-363.
78. Quintana, J.B., Weiss, S., and Reemtsma, T. (2005) Pathways and metabolites of microbial degradation of selected acidic pharmaceutical and their occurrence in municipal wastewater treated by a membrane bioreactor. Water Research, 39, 2654-2664.
79. Trautwain, C., Kümmerer, K. (2012) Incomplete aerobic degradation of the antidiabetic drug Metformin and identification of the bacterial dead-end transformation product Guanylurea. Chemosphere, 85(5), 765-773.
80. Jung, C.M., Heinze, T.M., Strakosha, R., Elkins, C.A., and Sutherland, J.B. (2009) Acetylation of fluoroquinolone antimicrobial agents by an Escherichia coli strain isolated from a municipal wastewater treatment plant. Journal of Applied Microbiology, 106(2), 564-571.
81. Haí, A., and Kümmerer, K. (2006) Biodegradability of the X-ray contrast compound diatrizoic acid, identification of aerobic degradation products and effects against sewage sludge microorganisms. Chemosphere, 62(2), 294-302.
82. Kalsch, W. (1999) Biodegradation of the iodinated X-ray contrast media diatrizoate and iopromide. The Science of the Total Environment, 225(1-2), 143-153.
83. Gröning, J., Held, C., Garten, C. et al. (2007) Transformation of diclofenac by the indigenous microflora of river sediments and identification of a major intermediate. Chemosphere, 69, 509-516.
84. Kosjek, T., Heath, E., and Kompare, B. (2007) Removal of pharmaceutical residues in a pilot wastewater treatment plant. Analytical and Bioanalytical Chemistry, 387, 1379-1387.
85. Zuehlke, S., Duennbier, U., and Heberer, T. (2007) Investigation of the behavior and metabolism of pharmaceutical residues during purification of contaminated ground water used for drinking water supply. Chemosphere, 69, 1673-1680.
86. Zwiener, C.Z., Seeger, S.S., Glauner, T.G., and Frimmel, F.F. (2002) Metabolites from the biodegradation of pharmaceutical residues of ibuprofen in biofilm reactors and batch experiments. Journal of Analytical and Bioanalytical Chemistry, 372, 569-575.
87. Winkler, M., Lawrence, J.R., and Neu, T.R. (2001) Selective degradation of ibuprofen and clofibric acid in two model river biofilm systems. Water Research, 35, 3197-3205.
88. Matamoros, V., Caselles-Osorio, A., García, J., and Bayona, J.M. (2008) Behaviour of pharmaceutical products and biodegradation intermediates in horizontal subsurface flow constructed wetland. A microcosm experiment. The Science of the Total Environment, 394, 171-176.
89. Marco-Urrea, E., Pérez-Trujillo, M., Vicent, T., and Caminal, G. (2009) Ability of white-rot fungi to remove selected pharmaceuticals and identification of degradation products of ibuprofen by Trametes versicolor. Chemosphere, 74, 765-772.
90. Perez, S., Eichhorn, P., Celiz, M.D., and Aga, D.S. (2006) Structural characterization of metabolites of the X-ray contrast agent Iopromide in activated sludge using Ion Trap Mass Spectrometry. Analytical Chemistry, 78, 1866-1874.
91. Steger-Hartmann, T., Länge, R., Schweinfurth, H. et al. (2002) Investigations into the environmental fate and effects of iopromide (ultravist), a widely used iodinated X-ray contrast medium. Water Research, 36, 266-274.
92. Scheurer, M., Michel, A., Brauch, H. et al. (2012) Occurrence and fate of the antidiabetic drug metformin and its metabolite guanylurea in the environment and during drinking water treatment. Water Research, 46, 4790-4802.
93. Trautwein, C. and Kümmerer, K. (2011) Incomplete aerobic degradation of the antidiabetic drug Metformin and identification of the bacterial dead-end transformation product Guanylurea. Chemosphere, 85, 765-773.
94. Zhong, D., Sun, L., Liu, L., and Huang, H. (2003) Microbial transformation of naproxen by Cunninghamella species. Acta Pharmacologica Sinica, 24, 442-447.
95. Adjei, M.D., Heinze, T.M., Deck, J., Freeman, J.P., Williams, A.J., and Sutherland, J.B. (2006) Transformation of the antibacterial agent norfloxacin by environmental mycobacteria. Applied and Environmental Microbiology, 72(9), 5790-5793.
96. García-Galán, M.J., Rodríguez-Rodríguez, C.E., Vicent, T. et al. (2011) Biodegradation of sulfamethazine by Trametes versicolor: Removal from sewage sludge and identification of intermediate products by UPLC-QqTOF-MS. The Science of the Total Environment, 409, 5505-5512.
97. Gauthier, H., Yargeau, V., and Cooper, D.G. (2010) Biodegradation of pharmaceuticals by Rhodococcus rhodochrous and Aspergillus niger by co-metabolism. The Science of the Total Environment, 408, 1701-1706.
98. Eichhorn, P., Ferguson, P.L., Perez, S., and Aga, D.S. (2005) Application of Ion Trap-MS with H/D exchange and QqTOF-MS in the identification of microbial degradates of trimethoprim in nitrifying activated sludge. Analytical Chemistry, 77, 4176-4184.
99. Yi, T., Barr, W., and Harper, W.F. (2012) Electron density-based transformation of trimethoprim during biological wastewater treatment. Water Science and Technology, 65(4), 689-696.
100. Trautwein, C., Kümmerer, K., and Metzger, J.W. (2008) Aerobic biodegradability of the calcium channel antagonist verapamil and identification of a microbial dead-end transformation product studied by LC-MS/MS. Chemosphere, 72(3), 442-450.
101. Buser, H., Poiger, T., and Muller, M.D. (1999) Occurrence and environmental behavior of the chiral pharmaceutical drug ibuprofen in surface waters and in wastewater. Environmental Science & Technology, 33, 2529-2535.
102. Matamoros, V., García, J., and Bayona, J.M. (2005) Behavior of selected pharmaceuticals in subsurface flow constructed wetlands: A pilot-scale study. Environmental Science & Technology, 39, 5449-5454.
103. Kormos, J.L., Schulz, M., Kohler, H.E., and Ternes, T.A. (2010) Biotransformation of selected iodinated X-ray contrast media and characterization of microbial transformation Pathways. Environmental Science & Technology, 44, 4998-5007.
104. Pérez, S., Eichhorn, P., Celiz, M.D., and Aga, D.S. (2006) Structural characterization of metabolites of the X-ray contrast agent Iopromide in activated sludge using ion trap mass spectrometry. Analytical Chemistry, 78, 1866-1874.
105. Radjenovíc, J., Pérez, S., Petrovíc, M., and Barceló, D. (2008) Identification and structural characterization of biodegradation products of atenolol and glibenclamide by liquid chromatography coupled to hybrid quadrupole time-of-flight and quadrupole ion trap mass spectrometry. Journal of Chromatography A, 1210(2), 142-153.
106. Wick, A., Wagner, M., and Ternes, T.A. (2011) Elucidation of the transformation pathway of the opium alkaloid codeine in biological wastewater treatment. Environmental Science & Technology, 45, 3374-3385.
107. Arnold, W.A. and McNeill, K. (2007) Transformation of pharmaceuticals in the environment: photolysis and other abiotic processes, in Analysis, Fate and Removal of Pharmaceuticals in the Water Cycle (ed. M. Petrovic and D. Barcelo), Elsevier Science, Amsterdam, Netherlands.
108. Agüera, A., Pérez Estrada, L.A., Ferrer, I. et al. (2005) Application of time-of-flight mass spectrometry to the analysis of phototransformation products of diclofenac in water under natural sunlight. Journal of Mass Spectrometry, 40, 908-915.
109. Buser, H., Poiger, T., and Muller, M.D. (1998) Occurrence and fate of the pharmaceutical drug diclofenac in surface waters: rapid photodegradation in a lake. Environmental Science & Technology, 32, 3449-3456.
110. Schmitt-Jansen, M., Bartels, P., Adler, N., and Altenburger, R. (2007) Phytotoxicity assessment of diclofenac and its phototransformation products. Analytical and Bioanalytical Chemistry, 387, 1389-1396.
111. Moore, D.E., Roberts-Thomson, S., Zhen, D., and Duke, C.C. (1990) Photochemical studies on the antiinflammatory drug diclofenac. Photochemistry and Photobiology, 52, 685-690.
112. Schulze, T., Weiss, S., Schymanski, E. et al. (2010) Identification of a phytotoxic photo-transformation product of diclofenac using effect-directed analysis. Environmental Pollution, 158, 1461-1466.
113. Moore, D.E. and Chappuis, P.P. (1988) A comparative study of the photochemistry of the nonsteroidal anti-inflammatory drugs, naproxen, benoxaproxen and indomethacin. Photochemistry and Photobiology, 47, 173-180.
114. DellaGreca, M., Brigante, M., Isidori, M. et al. (2003) Phototransformation and ecotoxicity of the drug Naproxen-Na. Environmental Chemistry Letters, 1, 237-241.
115. Isidori, M., Lavorgna, M., Nardelli, A. et al. (2005) Ecotoxicity of naproxen and its phototransformation products. The Science of the Total Environment, 348, 93-101.
116. Castell, J.V., Gomez-L., M.J., Miranda, M.A., and Morera, I.M. (1987) Photolytic degradation of ibuprofen. Toxicity of the isolated photoproducts on fibroblasts and erythrocytes. Photochemistry and Photobiology, 46, 991-996.
117. Matamoros, V., Aurélie, D., Albaigés, J., and Bayona, J. (2009) Photodegradation of carbamazepine, ibuprofen, ketoprofen and 17a-ethinylestradiol in fresh and seawater. Water, Air, & Soil Pollution, 196, 161-168.
118. Nakajima, A., Tahara, M., Yoshimura, Y., and Nakazawa, H. (2005) Determination of free radicals generated from light exposed ketoprofen. Journal of Photochemistry and Photobiology A, 174, 89-97.
119. Gómez, M.J., Sirtori, C., Mezcua, M. et al. (2008) Photodegradation study of three dipyrone metabolites in various water systems: Identification and toxicity of their photodegradation products. Water Research, 42, 2698-2706.
120. Chiron, S., Minero, C., and Vione, D. (2006) Photodegradation processes of the antiepileptic drug carbamazepine, relevant to estuarine waters. Environmental Science & Technology, 40, 5977-5983.
121. Lam, M.W. and Mabury, S.A. (2005) Photodegradation of the pharmaceuticals atorvastatin, carbamazepine, levofloxacin, and sulfamethoxazole in natural waters. Aquatic Sciences, 67, 177-188.
122. Zhou, W. and Moore, D.E. (1994) Photochemical decomposition of sulfamethoxazole. International Journal of Pharmaceutics, 110, 55-63.
123. Sirtori, C., Agüera, A., Gernjak, W., and Malato, S. (2010) Effect of water-matrix composition on Trimethoprim solar photodegradation kinetics and pathways. Water Research, 44, 2735-2744.
124. Maquille, A. and Habib Jiwan, J. (2009) LC-MS characterization of metoclopramide photolysis products. Journal of Photochemistry and Photobiology A, 205, 197-202.
125. Maquille, A., Salembier, S., Hérent, M., and Habib Jiwan, J. (2010) Photodegradation of flupentixol in aqueous solution under irradiation at 254nm: Identification of the photoproducts generated. Journal of Photochemistry and Photobiology A, 214, 224-229.
126. Liu, Q. and Williams, H.E. (2007) Kinetics and degradation products for direct photolysis of b-blockers in water. Environmental Science & Technology, 41, 803-810.
127. Liu, Q., Cumming, R.I., and Sharpe, A.D. (2009) Photo-induced environmental depletion processes of b-blockers in river waters. Photochemical & Photobiological Sciences, 8, 768-777.
128. Dantas, R.F., Rossiter, O., Teixeira, A.K.R. et al. (2010) Direct UV photolysis of propranolol and metronidazole in aqueous solution. Chemical Engineering Journal, 158, 143-147.
129. Jiao, S., Zheng, S., Yin, D. et al. (2008) Aqueous photolysis of tetracycline and toxicity of photolytic products to luminescent bacteria. Chemosphere, 73, 377-382.
130. Vasconcelos, T.G., Henriques, D.M., König, A. et al. (2009) Photo-degradation of the antimicrobial ciprofloxacin at high pH: Identification and biodegradability assessment of the primary byproducts. Chemosphere, 76, 487-493.
131. Kusari, S., Prabhakaran, D., Lamshöft, M., and Spiteller, M. (2009) In vitro residual anti-bacterial activity of difloxacin, sarafloxacin and their photoproducts after photolysis in water. Environmental Pollution, 157, 2722-2730.
132. Cermola, M., DellaGreca, M., Iesce, M.R. et al. (2005) Phototransformation of fibrate drugs in aqueous media. Environmental Chemistry Letters, 3, 43-47.
133. Brigante, M., DellaGreca, M., Previtera, L. et al. (2005) Degradation of hydrochlorothiazide in water. Environmental Chemistry Letters, 2, 195-198.
134. DellaGreca, M., Iesce, M.R., Isidori, M., Nardelli, A., Previtera, L., and Rubino, M. (2007) Phototransformation products of tamoxifen by sunlight in water. Toxicity of the drug and its derivatives on aquatic organisms. Chemosphere, 67 (10), 1933-1939.
135. Isidori, M., Nardelli, A., Pascarella, L., Rubino, M., and Parrella, A. (2007) Toxic and genotoxic impact of fibrates and their photoproducts on non-target organisms. Environment International, 33, 635-641.
136. Mahmoud, W.M.M., and Kümmerer, K. (2012) Captopril and its dimer captopril disulfide: Photodegradation, aerobic biodegradation and identification of transformation products by HPLC-UV and LC-ion trap-MSn. Chemosphere, 88(10), 1170-1177.
137. Moore, D.E. (1998) Mechanisms of photosensitization by phototoxic drugs. Mutation Research, 422, 165-173.
138. Encinas, S., Bosca, F., and Miranda, M.A. (1998) Photochemistry of 2,6-dichlorodiphenylamine and 1-chlorocarbazole, the photoactive chromophores of diclofenac, meclofenamic acid and their major photoproducts. Photochemistry and Photobiology, 68, 640-645.
139. Poiger, T., Buser, H., and Müller, M.D. (2001) Photodegradation of the pharmaceutical drug diclofenac in a lake: Pathway, field measurements, and mathematical modeling. Environmental Toxicology and Chemistry, 20, 256-263.
140. Scott G. (1965) Atmospheric Oxidation and Antioxidants (ed. G. Scott), Elsevier, Amsterdam.
141. Andreozzi, R., Marotta, R., Pinto, G., and Pollio, A. (2002) Carbamazepine in water: persistence in the environment, ozonation treatment and preliminary assessment on algal toxicity. Water Research, 36, 2869-2877.
142. Doll, T.E. and Frimmel, F.H. (2004) Kinetic study of photocatalytic degradation of carbamazepine, clofibric acid, iomeprol and iopromide assisted by different TiO2 materials-determination of intermediates and reaction pathways. Water Research, 38, 955-964.
143. Vogna, D., Marotta, R., Napolitano, A. et al. (2004) Advanced oxidation of the pharmaceutical drug diclofenac with UV/H2O2 and ozone. Water Research, 38, 414-422.
144. Eliopoulos, G.M., Moellering, A.E., Reiszner, E., and Moellering, R.C. (1985) In vitro activities of the quinolone antimicrobial agents A-56619 and A-56620. Antimicrobial Agents and Chemotherapy, 28, 514-520.
145. Stamm, J.M., Hanson, C.W., Chu, D.T. et al. (1986) In vitro evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones. Antimicrobial Agents and Chemotherapy, 29, 193-200.
146. Sukul, P., Lamshöft, M., Kusari, S. et al. (2009) Metabolism and excretion kinetics of 14Clabeled and non-labeled difloxacin in pigs after oral administration, and antimicrobial activity of manure containing difloxacin and its metabolites. Environmental Research, 109, 225-231.
147. Sunderland, J., Tobin, C.M., Hedges, A.J. et al. (2001) Antimicrobial activity of fluoroquinolone photodegradation products determined by parallel-line bioassay and high performance liquid chromatography. The Journal of Antimicrobial Chemotherapy, 47, 271-275.
148. Garcia-Käufer, M., Haddad, T., Bergheim, M. et al. (2012) Genotoxic effect of ciprofloxacin during photolytic decomposition monitored by the in vitro micronucleus test (MNvit) in HepG2 cells. Environmental Science and Pollution Research, 19, 1719-1727.
149. Vasquez, M.I., Garcia-Käufer, M., Hapeshi, E. et al. (2012) Chronic ecotoxic effects to Pseudomonas putida and Vibrio fischeri, and cytostatic and genotoxic effects to the hepatoma cell line (HepG2) of ofloxacin photo(cata)lytically treated solutions. The Science of the Total Environment, 450-451, 356-365.
150. Vasquez, M., Hapeshi, E., Fatta-Kassinos, D., and Kümmerer, K. (2012) Biodegradation potential of ofloxacin and its resulting transformation products during photolytic and photocatalytic treatment. Environmental Science and Pollution Research, 20(3), 1302-1309.
151. Gómez, M.J., Sirtori, C., Mezcua, M., Fernández-Alba, A.R., and Agüera, A. (2008) Photodegradation study of three dipyrone metabolites in various water systems: Identification and toxicity of their photodegradation products. Water Research, 42(10-11), 2698-2706.
152. Coelho, A.D., Sans, C., Agüera, A. et al. (2009) Effects of ozone pre-treatment on diclofenac: Intermediates, biodegradability and toxicity assessment. The Science of the Total Environment, 407, 3572-3578.
153. Trovó, A.G., Pupo Nogueira, R.F., Agüera, A. et al. (2011) Degradation of the antibiotic amoxicillin by photo-Fenton process-Chemical and toxicological assessment. Water Research, 45, 1394-1402.
154. Trovó, A.G., Nogueira, R.F.P., Agüera, A. et al. (2009) Degradation of sulfamethoxazole in water by solar photo-Fenton. Chemical and toxicological evaluation. Water Research, 43, 3922-3931.
155. Sirtori, C., Zapata, A., Gernjak, W. et al. (2011) Solar photo-Fenton degradation of nalidixic acid in waters and wastewaters of different composition. Analytical assessment by LC-TOF-MS. Water Research, 45, 1736-1744.
156. Michael, I., Hapeshi, E., Osorio, V. et al. (2012) Solar photocatalytic treatment of trimethoprim in four environmental matrices at a pilot scale: Transformation products and ecotoxicity evaluation. The Science of the Total Environment, 430, 167-173.
157. Sirés, I., Oturan, N., Oturan, M.A. et al. (2007) Electro-Fenton degradation of antimicrobials triclosan and triclocarban. Electrochimica Acta, 52, 5493-5503.
158. Méndez-Arriaga, F., Esplugas, S., and Giménez, J. (2010) Degradation of the emerging contaminant ibuprofen in water by photo-Fenton. Water Research, 44, 589-595.
159. Radjenovíc, J., Petrovíc, M., and Barceló, D. (2009) Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment. Water Research, 43, 831-841.
160. Baran, W., Adamek, E., Sobczak, A., and Makowski, A. (2009) Photocatalytic degradation of sulfa drugs with TiO2, Fe salts and TiO2/FeCl3 in aquatic environment-Kinetics and degradation pathway. Applied Catalysis B: Environmental, 90, 516-525.
161. Radjenovíc, J., Sirtori, C., Petrovíc, M. et al. (2010) Characterization of intermediate products of solar photocatalytic degradation of ranitidine at pilot-scale. Chemosphere, 79, 368-376.
162. Vione, D., Feitosa-Felizzola, J., Minero, C., and Chiron, S. (2009) Phototransformation of selected human-used macrolides in surface water: Kinetics, model predictions and degradation pathways. Water Research, 43, 1959-1967.
163. Sirtori, C., Zapata, A., Malato, S. et al. (2009) Solar photocatalytic treatment of quinolones: intermediates and toxicity evaluation. Photochemical & Photobiological Sciences, 8, 644-651.
164. Hu, L., Flanders, P.M., Miller, P.L., and Strathmann, T.J. (2007) Oxidation of sulfamethoxazole and related antimicrobial agents by TiO2 photocatalysis. Water Research, 41, 2612-2626.
165. Sakkas, V.A., Calza, P., Medana, C. et al. (2007) Heterogeneous photocatalytic degradation of the pharmaceutical agent salbutamol in aqueous titanium dioxide suspensions. Applied Catalysis B: Environmental, 77, 135-144.
166. Zhang, X., Wu, F., Wu, X. et al. (2008) Photodegradation of acetaminophen in TiO2 suspended solution. Journal of Hazardous Materials, 157, 300-307.
167. Hofmann, J., Freier, U., Wecks, M., and Hohmann, S. (2007) Degradation of diclofenac in water by heterogeneous catalytic oxidation with H2O2. Applied Catalysis B: Environmental, 70, 447-451.
168. Calza, P., Sakkas, V.A., Medana, C. et al. (2006) Photocatalytic degradation study of diclofenac over aqueous TiO2 suspensions. Applied Catalysis B: Environmental, 67, 197-205.
169. Méndez-Arriaga, F., Esplugas, S., and Giménez, J. (2008) Photocatalytic degradation of non-steroidal anti-inflammatory drugs with TiO2 and simulated solar irradiation. Water Research, 42, 585-594.
170. Giraldo, A.L., Peñuela, G.A., Torres-Palma, R.A. et al. (2010) Degradation of the antibiotic oxolinic acid by photocatalysis with TiO2 in suspension. Water Research, 44, 5158-5167.
171. Lambropoulou, D.A., Hernando, M.D., Konstantinou, I.K. et al. (2008) Identification of photocatalytic degradation products of bezafibrate in TiO2 aqueous suspensions by liquid and gas chromatography. Journal of Chromatography A, 1183, 38-48.
172. Paul, T., Dodd, M.C., and Strathmann, T.J. (2010) Photolytic and photocatalytic decomposition of aqueous ciprofloxacin: Transformation products and residual antibacterial activity. Water Research, 44, 3121-3132.
173. Gómez-Ramos, M.d.M., Mezcua, M., Agüera, A. et al. (2011) Chemical and toxicological evolution of the antibiotic sulfamethoxazole under ozone treatment in water solution. Journal of Hazardous Materials, 192, 18-25.
174. Radjenovic, J., Godehardt, M., Petrovic, M. et al. (2009) Evidencing generation of persistent ozonation products of antibiotics roxithromycin and trimethoprim. Environmental Science & Technology, 43, 6808-6815.
175. Rosal, R., Gonzalo, M.S., Boltes, K. et al. (2009) Identification of intermediates and assessment of ecotoxicity in the oxidation products generated during the ozonation of clofibric acid. Journal of Hazardous Materials, 172, 1061-1068.
176. Vogna, D., Marotta, R., Andreozzi, R. et al. (2004) Kinetic and chemical assessment of the UV/ H2O2 treatment of antiepileptic drug carbamazepine. Chemosphere, 54, 497-505.
177. Santiago, J., Agüera, A., del Mar Gómez-Ramos, M. et al. (2011) Oxidation by-products and ecotoxicity assessment during the photodegradation of fenofibric acid in aqueous solution with UVand UV/H2O2. Journal of Hazardous Materials, 194, 30-41.
178. Yuan, F., Hu, C., Hu, X., Wie, D., Chen, Y., and Qu, J. (2011) Photodegradation and toxicity changes of antibiotics in UV and UV/H2O2 process. Journal of Hazardous Materials, 185, 1256-1263.
179. Méndez-Arriaga, F., Esplugas, S., and Giménez, J. (2008) Photocatalytic degradation of nonsteroidal anti-inflammatory drugs with TiO2 and simulated solar irradiation. Water Research, 42, 585-594.
180. Méndez-Arriaga, F., Esplugas, S., and Giménez, J. (2010) Degradation of the emerging contaminant ibuprofen in water by photo-Fenton. Water Research, 44, 589-595.
181. Gómez-Ramos, M., Mezcua, M., Aguera, A., Fernández-Alba, A.R., Gonzalo, S., Rodríguez, A., and Rosal, R. (2011) Chemical and toxicological evolution of the antibiotic sulfamethoxazole under ozone treatment in water solution. Journal of Hazardous Materials, 192(1), 18-25.
182. Martinez, L.J., Li, G., and Chignell, C.F. (1997) Photogeneration of fluoride by the fluoroquinolone antimicrobial agents lomefloxacin and fleroxacin. Photochemistry and Photobiology, 65, 599-602.
183. Giraldo, A.L., Penuela, G.A., Torres-Palma, R.A., Pino, N.J., Palominos, R.A., and Mansilla, H. D. (2010) Degradation of the antibiotic oxolinic acid by photocatalysis with TiO2 in suspension. Water Research, 44, 5158-5167.
184. Luo, X., Zheng, Z., Greaves, J. et al. (2012) Trimethoprim: Kinetic and mechanistic considerations in photochemical environmental fate and AOP treatment. Water Research, 46, 1327-1336.
185. Paul, T., Miller, P.L., and Strathmann, T.J. (2007) Visible-light-mediated TiO2 photocatalysis of fluoroquinolone antibacterial agents. Environmental Science & Technology, 41, 4720-4727.
186. 2+ and UVA light as catalysts. Applied Catalysis B: Environmental, 72, 373-381.
187. Prasse, C., Wagner, M., Schulz, R., and Ternes, T.A. (2012) Oxidation of the antiviral drug acyclovir and its biodegradation product carboxy-acyclovir with ozone: kinetics and identification of oxidation products. Environmental Science & Technology, 46, 2169-2178.